Skip to main content
Clinical Trials/NL-OMON41141
NL-OMON41141
Completed
Not Applicable

Assessing the safety and performance of a hip resurfacing prosthesis compared with a conventional total hip prosthesis in relatively young males with primary arthritis; a prospective, controlled clinical study. - BHR2014 study

Kliniek Orthopedium0 sites200 target enrollmentTBD

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Arthritis of the hip
Sponsor
Kliniek Orthopedium
Enrollment
200
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional

Investigators

Sponsor
Kliniek Orthopedium

Eligibility Criteria

Inclusion Criteria

  • 1\.Male patients between 18 and 60 years of age
  • 2\.Patients requiring primary hip replacement
  • 3\.Patients with an endstage of primary arthritis of the hip
  • 4\.Patients with a femoral head \* 50 mm (as measured by calibrated X\-ray imaging)

Exclusion Criteria

  • 1\.Patients with a BMI \>35
  • 2\.Patients with infection or sepsis
  • 3\.Patients with bone stock inadequate to support the device including:
  • a.Patients with severe osteopenia or with a family history of severe osteoporosis or severe osteopenia
  • b.Patients with osteonecrosis or avascular necrosis (AVN) with \>50% involvement of the femoral head (regardless
  • of FICAT grade)
  • c.Patients with multiple cysts of the femoral head (\> 1cm)
  • 4\.Patients with known moderate to severe renal insufficiency
  • 5\.Patients who are immunologically suppressed with diseases such as AIDS, or patients who are receiving
  • corticosteroids in high doses

Outcomes

Primary Outcomes

Not specified

Similar Trials